Selected research
Industry Growth & Trends
Global Diabetic Retinopathy Screening Solution Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Diabetic Retinopathy Screening Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Diabetic Retinopathy Screening Solution market include RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk and Thirona Retina, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Diabetic Retinopathy Screening Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Diabetic Retinopathy Screening Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetic Retinopathy Screening Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetic Retinopathy Screening Solution.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Diabetic Retinopathy Screening Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Diabetic Retinopathy Screening Solution Market by Company
RETINA-AI Health
IRIS
Retina Labs
CheckEye
RetinaLyze
NEC Software
InHealth Intelligence
RetinaRisk
Thirona Retina
Synapxe
Eyenuk
EyRIS (SELENA+)
Vistel
Diabetic Retinopathy Screening Solution Segment by Type
Traditional
Artificial Intelligence
Others
Diabetic Retinopathy Screening Solution Segment by Application
Medical Industry
Scientific Research
Others
Diabetic Retinopathy Screening Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Diabetic Retinopathy Screening Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional
- Artificial Intelligence
- Others
Applications
- Medical Industry
- Scientific Research
- Others
Companies covered
- RETINA-AI Health
- IRIS
- Retina Labs
- CheckEye
- RetinaLyze
- NEC Software
- InHealth Intelligence
- RetinaRisk
- Thirona Retina
- Synapxe
- Eyenuk
- EyRIS (SELENA+)
- Vistel
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Diabetic Retinopathy Screening Solution Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Diabetic Retinopathy Screening Solution Market Size by Region (2021-2032)
- 1.4.1 Global Diabetic Retinopathy Screening Solution Market Size by Region (2021-2026)
- 1.4.2 Global Diabetic Retinopathy Screening Solution Market Size by Region (2027-2032)
- 1.5 Key Regions Diabetic Retinopathy Screening Solution Market Size (2021-2032)
- 1.5.1 North America Diabetic Retinopathy Screening Solution Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Diabetic Retinopathy Screening Solution Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size Growth Rate (2021-2032)
- 1.5.4 South America Diabetic Retinopathy Screening Solution Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size Growth Rate (2021-2032)
2 Diabetic Retinopathy Screening Solution Market by Type
- 2.1 Type Introduction
- 2.1.1 Traditional
- 2.1.2 Artificial Intelligence
- 2.1.3 Others
- 2.2 Global Diabetic Retinopathy Screening Solution Market Size by Type
- 2.2.1 Global Diabetic Retinopathy Screening Solution Market Size Overview by Type (2021-2032)
- 2.2.2 Global Diabetic Retinopathy Screening Solution Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Diabetic Retinopathy Screening Solution Market Size Forecasted by Type (2027-2032)
- 2.3 Global Diabetic Retinopathy Screening Solution Market Size by Regions
- 2.3.1 North America Diabetic Retinopathy Screening Solution Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Diabetic Retinopathy Screening Solution Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Diabetic Retinopathy Screening Solution Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Diabetic Retinopathy Screening Solution Market Size Breakdown by Type (2021-2026)
3 Diabetic Retinopathy Screening Solution Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Industry
- 3.1.2 Scientific Research
- 3.1.3 Others
- 3.2 Global Diabetic Retinopathy Screening Solution Market Size by Application
- 3.2.1 Global Diabetic Retinopathy Screening Solution Market Size Overview by Application (2021-2032)
- 3.2.2 Global Diabetic Retinopathy Screening Solution Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Diabetic Retinopathy Screening Solution Market Size Forecasted by Application (2027-2032)
- 3.3 Global Diabetic Retinopathy Screening Solution Market Size by Regions
- 3.3.1 North America Diabetic Retinopathy Screening Solution Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Diabetic Retinopathy Screening Solution Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Diabetic Retinopathy Screening Solution Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Diabetic Retinopathy Screening Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Diabetic Retinopathy Screening Solution Industry Trends
- 4.2 Diabetic Retinopathy Screening Solution Industry Drivers
- 4.3 Diabetic Retinopathy Screening Solution Industry Opportunities and Challenges
- 4.4 Diabetic Retinopathy Screening Solution Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Diabetic Retinopathy Screening Solution Revenue (2021-2026)
- 5.2 Global Diabetic Retinopathy Screening Solution Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Diabetic Retinopathy Screening Solution Key Company Headquarters & Area Served
- 5.4 Global Diabetic Retinopathy Screening Solution Company, Product Type & Application
- 5.5 Global Diabetic Retinopathy Screening Solution Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Diabetic Retinopathy Screening Solution Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Diabetic Retinopathy Screening Solution Players Market Share by Revenue in 2025
- 5.6.3 2025 Diabetic Retinopathy Screening Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 RETINA-AI Health
- 6.1.1 RETINA-AI Health Company Information
- 6.1.2 RETINA-AI Health Business Overview
- 6.1.3 RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 RETINA-AI Health Diabetic Retinopathy Screening Solution Product Portfolio
- 6.1.5 RETINA-AI Health Recent Developments
- 6.2 IRIS
- 6.2.1 IRIS Company Information
- 6.2.2 IRIS Business Overview
- 6.2.3 IRIS Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 IRIS Diabetic Retinopathy Screening Solution Product Portfolio
- 6.2.5 IRIS Recent Developments
- 6.3 Retina Labs
- 6.3.1 Retina Labs Company Information
- 6.3.2 Retina Labs Business Overview
- 6.3.3 Retina Labs Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Retina Labs Diabetic Retinopathy Screening Solution Product Portfolio
- 6.3.5 Retina Labs Recent Developments
- 6.4 CheckEye
- 6.4.1 CheckEye Company Information
- 6.4.2 CheckEye Business Overview
- 6.4.3 CheckEye Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CheckEye Diabetic Retinopathy Screening Solution Product Portfolio
- 6.4.5 CheckEye Recent Developments
- 6.5 RetinaLyze
- 6.5.1 RetinaLyze Company Information
- 6.5.2 RetinaLyze Business Overview
- 6.5.3 RetinaLyze Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 RetinaLyze Diabetic Retinopathy Screening Solution Product Portfolio
- 6.5.5 RetinaLyze Recent Developments
- 6.6 NEC Software
- 6.6.1 NEC Software Company Information
- 6.6.2 NEC Software Business Overview
- 6.6.3 NEC Software Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 NEC Software Diabetic Retinopathy Screening Solution Product Portfolio
- 6.6.5 NEC Software Recent Developments
- 6.7 InHealth Intelligence
- 6.7.1 InHealth Intelligence Company Information
- 6.7.2 InHealth Intelligence Business Overview
- 6.7.3 InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 InHealth Intelligence Diabetic Retinopathy Screening Solution Product Portfolio
- 6.7.5 InHealth Intelligence Recent Developments
- 6.8 RetinaRisk
- 6.8.1 RetinaRisk Company Information
- 6.8.2 RetinaRisk Business Overview
- 6.8.3 RetinaRisk Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 RetinaRisk Diabetic Retinopathy Screening Solution Product Portfolio
- 6.8.5 RetinaRisk Recent Developments
- 6.9 Thirona Retina
- 6.9.1 Thirona Retina Company Information
- 6.9.2 Thirona Retina Business Overview
- 6.9.3 Thirona Retina Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Thirona Retina Diabetic Retinopathy Screening Solution Product Portfolio
- 6.9.5 Thirona Retina Recent Developments
- 6.10 Synapxe
- 6.10.1 Synapxe Company Information
- 6.10.2 Synapxe Business Overview
- 6.10.3 Synapxe Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Synapxe Diabetic Retinopathy Screening Solution Product Portfolio
- 6.10.5 Synapxe Recent Developments
- 6.11 Eyenuk
- 6.11.1 Eyenuk Company Information
- 6.11.2 Eyenuk Business Overview
- 6.11.3 Eyenuk Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Eyenuk Diabetic Retinopathy Screening Solution Product Portfolio
- 6.11.5 Eyenuk Recent Developments
- 6.12 EyRIS (SELENA+)
- 6.12.1 EyRIS (SELENA+) Company Information
- 6.12.2 EyRIS (SELENA+) Business Overview
- 6.12.3 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Portfolio
- 6.12.5 EyRIS (SELENA+) Recent Developments
- 6.13 Vistel
- 6.13.1 Vistel Company Information
- 6.13.2 Vistel Business Overview
- 6.13.3 Vistel Diabetic Retinopathy Screening Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Vistel Diabetic Retinopathy Screening Solution Product Portfolio
- 6.13.5 Vistel Recent Developments
7 North America
- 7.1 North America Diabetic Retinopathy Screening Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 7.3 North America Diabetic Retinopathy Screening Solution Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Diabetic Retinopathy Screening Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 8.3 Europe Diabetic Retinopathy Screening Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Diabetic Retinopathy Screening Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 10.3 South America Diabetic Retinopathy Screening Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst